title: [Expert statements concerning the Seroxat issue].
authors.forename: Edmund
authors.initials: E
authors.lastname: Asbøll
mesh_terms: D016265:Conflict of Interest; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects
chemical_list: D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors